Walleye Capital’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$260K Buy
9,500
+8,500
+850% +$302K ﹤0.01% 3164
2025
Q4
$41.6K Sell
1,000
-2,600
-72% -$105K ﹤0.01% 4124
2025
Q3
$166K Sell
3,600
-600
-14% -$32K ﹤0.01% 3432
2025
Q2
$222K Sell
4,200
-28,100
-87% -$1.48M ﹤0.01% 3280
2025
Q1
$1.8M Buy
32,300
+10,600
+49% +$508K 0.01% 1497
2024
Q4
$939K Buy
+21,700
New +$965K ﹤0.01% 2440
2024
Q3
Sell
-20,400
Closed -$1.29M 5376
2024
Q2
$1.29M Buy
20,400
+3,400
+20% +$204K ﹤0.01% 2571
2024
Q1
$1.13M Buy
17,000
+13,200
+347% +$1.07M ﹤0.01% 2480
2023
Q4
$373K Sell
3,800
-6,900
-64% -$601K ﹤0.01% 3174
2023
Q3
$857K Sell
10,700
-8,000
-43% -$628K ﹤0.01% 2375
2023
Q2
$1.51M Buy
+18,700
New +$1.75M 0.01% 1523
2022
Q4
Sell
-2,900
Closed -$324K 3244
2022
Q3
$324K Buy
+2,900
New +$371K 0.01% 1778

Other funds holding CNXC

Walleye Capital's CNXC Position: Q4 2025 in Review

Walleye Capital sold out of Concentrix (CNXC) in Q4 2025, closing a stake of 823 shares — an estimated $33.4K sold.

Walleye Capital first reported a position in CNXC in Q4 2021 and held it in 9 quarters. The position peaked at $3.49M in Q2 2023. 336 funds tracked by Wall St. Rank hold CNXC as of Q4 2025.

  • Walleye Capital reported no remaining Concentrix position as of Q4 2025 after selling out during the quarter.
  • Walleye Capital sold 823 Concentrix shares in Q4 2025, an estimated $33.4K.
  • Walleye Capital first reported a position in Concentrix in Q4 2021 and held it in 9 quarters.
  • Walleye Capital's Concentrix position peaked at $3.49M in Q2 2023.
  • 336 funds tracked by Wall St. Rank held Concentrix as of Q4 2025.

Based on Walleye Capital's 13F filing for Q4 2025, filed 13 Feb 2026.